LONDRA–(BUSINESS WIRE)–Oribiotech Ltd. (Ori), un leader nella tecnologia di produzione della terapia cellulare e genica (CGT) all’avanguardia, oggi ha annunciato una collaborazione strategica con un’azienda biofarmaceutica per integrare la piattaforma IRO® in un processo di produzione commerciale per la terapia cellulare in un accordo del valore massimo di 120 milioni di dollari in servizi, milestone, apparecchiature e acquisti di consumabili nei prossimi 10 anni. La collaborazione è progetta

PHOENIX–(BUSINESS WIRE)– #AmericanSolar–First Solar, Inc. (Nasdaq: FSLR) (“First Solar” or “the Company”) today announced a recalibration of its intellectual property (IP) enforcement strategy and its intent to voluntarily withdraw its Section 337 complaint and move to terminate the investigation currently pending before the US International Trade Commission (USITC) without prejudice to refiling at a later date. The Company will continue pursuing its existing TOPCon patent lawsuits in US District Court, incl

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.